Urgent

Hypoglycaemia (sulfonylurea-induced)

Prolonged risk · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Sulfonylureas cause prolonged, recurrent low glucose. After correcting the glucose, octreotide and admission prevent rebound.

Assessment

Investigations

  • Capillary and lab glucose
  • Drug history
  • Renal function

Management

  • Correct the glucose (oral/IV)
  • Octreotide for sulfonylurea cases
  • Admit and monitor (prolonged risk)
  • Avoid simply discharging after one correction
  • Review medication

Drugs & doses

Glucose
Octreotide

Disposition

Admit and observe.

A single glucose correction is not enough — sulfonylurea lows recur.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.